Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Finish Line Q4 Profit Grows - Quick Facts

RELATED NEWS
Trade FINL now with 

Finish Line Inc. (FINL: Quote) posted higher fourth-quarter net income of $41.92 million or $0.80 per share compared with $34.25 million or $0.63 per share last year.

On a non-GAAP basis, net profit improved to $42.52 million or $0.81 per share from the prior-year quarter's $35.02 million or $0.65 per share. On average, 12 analysts polled by Thomson Reuters expected earnings per share of $0.81 for the quarter. Analysts' estimates typically exclude one-time items.

Consolidated net sales, inclusive of Finish Line and The Running Company, rose 18.6% to $456.3 million from $384.6 million in the earlier year quarter. Ten analysts estimated revenues of $432.62 million for the quarter.

Click here to receive FREE breaking news email alerts for Finish Line Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. Citing extreme fluctuation of the ruble, Apple Inc. (AAPL) has reportedly discontinued its online sales of products in Russia. Despite efforts of the Russian central bank, the ruble has been spiraling downward, with oil prices plunging to historic levels. The ruble shed around 19 percent on Wednesday.... General Motors said it has halted the delivery of cars to dealerships in Russia as it strives to overcome the business risks stemming from the collapse of the ruble.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.